Patents by Inventor Richard Daifuku

Richard Daifuku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODRUGS OF HETEROARYL COMPOUNDS
    Publication number: 20070219200
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: May 15, 2007
    Publication date: September 20, 2007
    Applicant: Koronos Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • 1,3,5-Triazines for Treatment of Viral Diseases
    Publication number: 20070207973
    Abstract: The present invention provides compounds and methods for treatment of viral diseases and cancer.
    Type: Application
    Filed: December 27, 2006
    Publication date: September 6, 2007
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • Prodrugs of heteroaryl compounds
    Patent number: 7244732
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Grant
    Filed: March 31, 2004
    Date of Patent: July 17, 2007
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • Mutagenic nucleoside analogs for the treatment of viral disease
    Patent number: 7244717
    Abstract: The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs. In particular, the invention provides 5-aldehydo-uracil nucleosides and derivatives thereof, and methods of administration thereof to increase the virus mutation rate in a virally infected cell.
    Type: Grant
    Filed: August 21, 2002
    Date of Patent: July 17, 2007
    Assignee: Koronis Pharmaceuticals, Incorporated
    Inventors: Ling Li, Alexander Gall, Richard Daifuku
  • 1,3,5-TRIAZINES FOR TREATMENT OF VIRAL DISEASES
    Publication number: 20070142310
    Abstract: The present invention provides compounds and methods for treatment of viral diseases and cancer.
    Type: Application
    Filed: February 6, 2007
    Publication date: June 21, 2007
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • Mutagenic nucleoside analogs for the treatment of viral disease
    Publication number: 20060142240
    Abstract: The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs.
    Type: Application
    Filed: February 13, 2006
    Publication date: June 29, 2006
    Inventors: Ling Li, Alexander Gall, Richard Daifuku
  • Prodrugs of heteroaryl compounds
    Publication number: 20050014752
    Abstract: The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.
    Type: Application
    Filed: March 31, 2004
    Publication date: January 20, 2005
    Applicant: Koronis Pharmaceuticals, Incorporated
    Inventors: Richard Daifuku, Alexande Gall, Dmitri Sergueev, Dina Sologub, Kevin Harris
  • 1,3,5-Triazines for treatment of viral diseases
    Publication number: 20040127436
    Abstract: The present invention provides compounds and methods for treatment of viral diseases and cancer.
    Type: Application
    Filed: September 24, 2003
    Publication date: July 1, 2004
    Applicant: Koronis Pharmaceuticals, Inc.
    Inventors: Richard Daifuku, Alexander Gall, Dmitri Sergueev
  • Mutagenic nucleoside analogs for the treatment of viral disease
    Publication number: 20030170872
    Abstract: The present invention relates to methods of treating viral disease using mutagenic nucleoside analogs.
    Type: Application
    Filed: August 21, 2002
    Publication date: September 11, 2003
    Applicant: Koronis Pharmaceuticals, Inc.
    Inventors: Ling Li, Alexander Gall, Richard Daifuku